QuidelOrtho
QDEL
13.42
+1.01
+8.14%
QuidelOrtho
US · QDEL
#3374 by market cap
13.42
+1.01
+8.14%
Live - 5344 symbols - heartbeat 147s ago
· 2026-10-09 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- Total institutional ownership fell 0.5 percentage points.
Institutional ownership
- Held by institutions
- 121.76% -0.50pp
- Institutions
- 286
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund94.29%
Hedge Fund21.54%
Public Company3.51%
Individual/Insider1.12%
Government Pension Fund0.97%
Private Company0.84%
Insurance Company0.34%
Family Office/Trust0.22%
Top holders as of 2026-06-30
BlackRock
16.34% · 11.20M sh
FMR
10.73% · 7.36M sh
Newtyn Management, LLC
9.66% · 6.63M sh
Vanguard Portfolio Management, LLC
6.03% · 4.14M sh
Vanguard Capital Management, LLC
5.14% · 3.52M sh
Neuberger Berman Investment Advisers LLC
4.93% · 3.38M sh
American Century Investment Management
4.82% · 3.31M sh
Rubric Capital Management LP
4.82% · 3.31M sh
Invesco Ltd.
4.48% · 3.07M sh
State Street Global Advisors
4.34% · 2.98M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 43 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Douglas Bryant | Chief Executive Officer | 0.17% |
| Kenneth Buechler | Independent Non-Executive Chairperson | 0.16% |
| Brian Blaser | President | 0.11% |
| Joseph Busky | Chief Financial Officer | 0.08% |
| Matthew Strobeck | Independent Director | 0.07% |
| Robert Bujarski | Chief Operating Officer | 0.07% |
| Kenneth Widder | Independent Director | 0.07% |
| Michelle Hodges | General Counsel | 0.06% |
| Mary Polan | Independent Director | 0.06% |
| Edward Michael | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Ronald Bowman | Chief Human Resources Officer | Derivative Exercise and Sale | -921 | $10.63 |
| 2026-09-14 | Ronald Bowman | Chief Human Resources Officer | Derivative Exercise and Retained | +1,645 | -- |
| 2026-08-14 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Sale | -162 | $14.30 |
| 2026-08-14 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Retained | +284 | -- |
| 2026-07-14 | Micah Young | Chief Financial Officer & Principal Financial Officer | Other Derivative Acquisition | +356,555 | -- |
| 2026-06-30 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Sale | -2,096 | $18.18 |
| 2026-06-30 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Retained | +3,701 | -- |
| 2026-06-24 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +369 | -- |
| 2026-06-24 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +3,698 | -- |
| 2026-06-24 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +15,532 | -- |
| 2026-06-24 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +1,997 | -- |
| 2026-06-24 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +6,656 | -- |
| 2026-06-24 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +15,532 | -- |
| 2026-06-24 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +3,661 | -- |
| 2026-06-24 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +12,204 | -- |
| 2026-06-24 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +15,532 | -- |
| 2026-06-24 | Edward Michael | Independent Director | Other Derivative Acquisition | +1,053 | -- |
| 2026-06-24 | Edward Michael | Independent Director | Other Derivative Acquisition | +3,513 | -- |
| 2026-06-24 | Edward Michael | Independent Director | Other Derivative Acquisition | +15,532 | -- |
| 2026-06-24 | Mary Polan | Independent Director | Other Derivative Acquisition | +1,664 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
QuidelOrtho discussion 0 comments